The financial trajectory of the exosome therapy market is decoupling from the broader, slower-growing regenerative medicine ...
The license agreement grants PranaX access to a core patent portfolio covering exosome manufacturing, engineering and therapeutic applications through a technology licensing agreement. This agreement ...
NEW ORLEANS, March 11, 2025 /PRNewswire/ -- A pioneering Phase 1 clinical trial, reported in a March 9, 2025, ScienceDaily article, is advancing stem cell therapies for Parkinson's disease. After over ...
As described in the publication, each treatment dose consisted of 1 ml of exosome solution, containing a defined range of exosome particle numbers, mixed with 5 ml of saline. The solution was ...
A new editorial paper was published in Oncotarget's Volume 14 on December 20, 2023, entitled, "Therapeutically harnessing cancer stem cell-derived exosomes." In this editorial, researcher Yong Teng ...
PrimeGen US, Inc. (“PrimeGen US" or the "Company”), a pioneering biotech company advancing innovative stem cell and exosome ...
Multidrug-resistant bacteria pose a major threat to human health. Manipulation of bacterial genes at the transcriptional level is a potential strategy to fight antibiotic-resistant bacterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results